Biotech Values

[JJM760]

Thanks, I figured as much. Don pointed out that MD Andersen trial was started in April of 2012. We should get a 12 month MMR readout, as well as a good look at the safety profile from that trial at ASH in December. There should be a very clear picture for Ponatinib in 6 months.